MedTrace Logo

Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents

NCT00795951 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-08-06

Study results available
· View outcomes & findings →

Summary

Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.

Conditions

  • Dermatitis, Contact

Interventions

BIOLOGICAL

T.R.U.E. Test

48 hour application of 28 allergens and negative control

Sponsors & Collaborators

  • Allerderm

    lead INDUSTRY

Principal Investigators

  • Lawrence Eichenfield, MD · UCSD School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-10-31
Completion
2009-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795951 on ClinicalTrials.gov